Literature DB >> 26090651

Lymphatic Interventions for Treatment of Chylothorax.

H H Schild1, C P Naehle1, K E Wilhelm1, C K Kuhl2, D Thomas1, C Meyer1, J Textor1, H Strunk1, W A Willinek1, C C Pieper1.   

Abstract

PURPOSE: To determine effectiveness of lymphatic interventional procedures for treatment of chylothorax.
MATERIAL AND METHODS: Analysis of interventions performed from 2001 to 2014.
RESULTS: In 21 patients with therapy resistant chylothorax a lymphatic radiological intervention was attempted, which could be performed in 19 cases: 17 thoracic duct embolizations (15 transabdominal, one transzervical and one retrograde transvenous procedure), 2 percutaneous destructions of lymphatic vessels, one CT-guided injection of ethanol next to a duplicated thoracic duct. Fourteen of seventeen (82.3 %) of the technically successful embolizations lead to clinical cure. This encluded three patients with prior unsuccessful surgical thoracic duct ligation. Also the injection of ethanol was clinically effective. Complications were a bile peritonitis requiring operation, and one clinical deterioration of unknown cause.
CONCLUSION: Interventional lymphatic procedures allow for effective treatment in many cases of chylothorax, and should be considered early during treatment. KEY POINTS: • Thoracic duct embolization is an effective treatment method for chylothorax. • If embolization is impossible, percutaneous lymphatic destruction or injection of sclerosants/tissue adhesive next to the thoracic duct may be tried. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26090651     DOI: 10.1055/s-0034-1399438

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  9 in total

Review 1.  Nodal and Pedal MR Lymphangiography of the Central Lymphatic System: Techniques and Applications.

Authors:  Claus Christian Pieper
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

2.  [Rare cause of a supraclavicular swelling].

Authors:  D Bartmann; T Koppen; C C Pieper; F Bootz; T Send
Journal:  HNO       Date:  2018-06       Impact factor: 1.284

Review 3.  Radiological management of postoperative lymphorrhea.

Authors:  C M Sommer; C C Pieper; F Offensperger; F Pan; H J Killguss; J Köninger; M Loos; T Hackert; M Wortmann; T D Do; G Maleux; G M Richter; H U Kauczor; J Kim; S Hur
Journal:  Langenbecks Arch Surg       Date:  2021-04-12       Impact factor: 3.445

4.  MR lymphangiography of lymphatic abnormalities in children and adults with Noonan syndrome.

Authors:  C C Pieper; J Wagenpfeil; A Henkel; S Geiger; T Köster; K Hoss; J A Luetkens; C Hart; U I Attenberger; A Müller
Journal:  Sci Rep       Date:  2022-07-01       Impact factor: 4.996

5.  In Vitro Evaluation of Acrylic Adhesives in Lymphatic Fluids-Influence of Glue Type and Procedural Parameters.

Authors:  Daniel Kuetting; Patrick Kupczyk; Tatjana Dell; Julian A Luetkens; Carsten Meyer; Ulrike I Attenberger; Claus C Pieper
Journal:  Biomedicines       Date:  2022-05-21

6.  Ultrasound-guided lymphangiography and interventional embolization of chylous leaks following esophagectomy.

Authors:  Rolf Lambertz; De-Hua Chang; Tilman Hickethier; Mahsa Bagheri; Jessica M Leers; Christiane J Bruns; Wolfgang Schröder
Journal:  Innov Surg Sci       Date:  2019-03-09

7.  Chemical Pleurodesis Using a Viscum album Extract in an Infant with Postoperative Chylothorax: A Case Report.

Authors:  Taeyoung Yun; Hye Won Kwon; Samina Park; Woong-Han Kim
Journal:  J Chest Surg       Date:  2022-02-05

8.  Lymphangiographic Interventions to Manage Postoperative Chylothorax.

Authors:  Hyuncheol Jeong; Hyo Yeong Ahn; Hoon Kwon; Yeong Dae Kim; Jeong Su Cho; Jungseop Eom
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2019-10-05

9.  Lymphatic imaging and intervention for chylothorax following thoracic aortic surgery.

Authors:  Cheng Shi Chen; Jong Woo Kim; Ji Hoon Shin; Hyun Jung Koo; Joon Bum Kim; Hai-Liang Li; Se Hwan Kwon; Alrashidi Ibrahim; Almoaiad A Alhazemi; Hee Ho Chu
Journal:  Medicine (Baltimore)       Date:  2020-08-21       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.